🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Medulloblastoma

Medulloblastoma Online Video-based Exercise Pilot Study NCT06898684NA2 sites📍 München📍 Gothenburg Aron Onerup · Tests: Exercise DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma NCT04696029Phase 226 sites📍 Little Rock📍 Oakland📍 Sacramento Giselle Sholler · Tests: Difluoromethylornithine Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease NCT07346157Phase 1, Phase 23 sites📍 San Francisco📍 Washington D.C.📍 Seattle Sabine Mueller, MD, PhD · Tests: Liothyronine (L-T3), Bevacizumab, Irinotecan, Temozolomide (TMZ) Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour NCT05230758Phase 320 sites📍 New Lambton Heights📍 Westmead📍 Adelaide Donald Mabbott · Tests: Metformin hydrochloride (HCl) 500mg tablet, Placebo Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043n/a1 site📍 Beijing Beijing Tiantan Hospital Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin Digoxin Medulloblastoma Study NCT06701812Phase 217 sites📍 Birmingham📍 Phoenix📍 Little Rock H. Lee Moffitt Cancer Center and Research Institute · Tests: Digoxin Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors NCT01356290Phase 222 sites📍 Chicago📍 Boston📍 Grand Rapids Medical University of Vienna · Tests: Bevacizumab, Thalidomide, Celecoxib, Fenofibric acid, Etoposide HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 International HIT-MED Registry (I-HIT-MED) NCT02417324n/a57 sites📍 Aachen📍 Augsburg📍 Berlin Universitätsklinikum Hamburg-Eppendorf Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) NCT06193759Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized… Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039EARLY Phase 112 sites📍 Calgary📍 Vancouver📍 Winnipeg C17 Council · Tests: Cytarabine IT, hydrocortisone, Cisplatin, Vincristine, Etoposide Atovaquone Combined With Radiation in Children With Malignant Brain Tumors NCT06624371Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Atovaquone, Radiation Therapy Pharmacoscopy for Patients With Refractory Primary Brain Tumors NCT06804655Phase 23 sites📍 Basel📍 Sankt Gallen📍 Zurich University of Zurich · Tests: Pharmacoscopy 1.0 A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss NCT05382338Phase 3111 sites📍 Birmingham📍 Mobile📍 Phoenix Children's Oncology Group · Tests: Audiometric Test, Auditory Brainstem Response, Biospecimen Collection, Cisplatin, Cyclophosphamide GD2-CAR T Cells for Pediatric Brain Tumours NCT05298995Phase 11 site📍 Roma Bambino Gesù Hospital and Research Institute · Tests: GD2-CART01 (iC9-GD2-CAR T-cells) A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) NCT04573140Phase 12 sites📍 Washington D.C.📍 Gainesville University of Florida · Tests: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP li… Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma NCT05535166Phase 210 sites📍 Palo Alto📍 Orlando📍 Tampa St. Jude Children's Research Hospital · Tests: Surgical resection, Ommaya/VPS, Methotrexate, Cisplatin, Vincristine Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline NCT06779487n/a1 site📍 Mumbai Tata Memorial Centre Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study NCT07242963n/a2 sites📍 Houston📍 Houston Mohammad H. Abu Arja A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies. NCT07017816EARLY Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors NCT07664176Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications NCT06161519Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: PLX038 Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma NCT05057702NA9 sites📍 Los Angeles📍 San Diego📍 San Francisco University of California, San Francisco · Tests: Specialized Tumor Board Treatment Plan, Combinations Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors NCT04185038Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback NCT07830134NA1 site📍 Memphis St. Jude Children's Research Hospital · Tests: rt fMRI Neurofeedback (DLPFC), rt fMRI Neurofeedback (PAC) Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms NCT04541082Phase 11 site📍 Bethesda Jazz Pharmaceuticals · Tests: ONC206 PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma NCT05096481Phase 213 sites📍 Aurora📍 Washington D.C.📍 Miami Nationwide Children's Hospital · Tests: PEP-CMV, Temozolomide, Tetanus Diphtheria Vaccine Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children NCT04501718Phase 21 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Apatinib Combined With Temozolomide and Etoposide Capsules
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy